- Home
- AXSM vs LBTYA Comparison
AXSM vs LBTYA Comparison
Compare AXSM & LBTYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- LBTYA
- Stock Information
- Founded
- AXSM 2012
- LBTYA 2004
- Country
- AXSM United States
- LBTYA Bermuda
- Employees
- AXSM N/A
- LBTYA N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- LBTYA Cable & Other Pay Television Services
- Sector
- AXSM Health Care
- LBTYA Telecommunications
- Exchange
- AXSM Nasdaq
- LBTYA Nasdaq
- Market Cap
- AXSM 4.8B
- LBTYA 4.0B
- IPO Year
- AXSM 2015
- LBTYA N/A
- Fundamental
- Price
- AXSM $104.46
- LBTYA $10.63
- Analyst Decision
- AXSM Strong Buy
- LBTYA Strong Buy
- Analyst Count
- AXSM 15
- LBTYA 3
- Target Price
- AXSM $171.00
- LBTYA $19.67
- AVG Volume (30 Days)
- AXSM 912.2K
- LBTYA 1.7M
- Earning Date
- AXSM 05-05-2025
- LBTYA 05-02-2025
- Dividend Yield
- AXSM N/A
- LBTYA N/A
- EPS Growth
- AXSM N/A
- LBTYA N/A
- EPS
- AXSM N/A
- LBTYA 4.23
- Revenue
- AXSM $385,693,000.00
- LBTYA $4,341,900,000.00
- Revenue This Year
- AXSM $63.85
- LBTYA $4.54
- Revenue Next Year
- AXSM $63.93
- LBTYA $0.02
- P/E Ratio
- AXSM N/A
- LBTYA $2.21
- Revenue Growth
- AXSM 42.53
- LBTYA 5.49
- 52 Week Low
- AXSM $64.11
- LBTYA $9.84
- 52 Week High
- AXSM $139.13
- LBTYA $21.56
- Technical
- Relative Strength Index (RSI)
- AXSM 41.94
- LBTYA 42.05
- Support Level
- AXSM $86.99
- LBTYA $10.44
- Resistance Level
- AXSM $103.75
- LBTYA $10.75
- Average True Range (ATR)
- AXSM 5.84
- LBTYA 0.41
- MACD
- AXSM -0.01
- LBTYA -0.02
- Stochastic Oscillator
- AXSM 56.74
- LBTYA 42.70
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About LBTYA Liberty Global Ltd.
Liberty Global is a holding company with interests in several telecom companies in the UK, the Netherlands, Belgium, Switzerland, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies, and has pursued a strategy since 2016 to merge or partner with mobile-network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.